Current role
Blai Coll, M.D., Ph.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Blai Coll, M.D., Ph.D.
Structure Therapeutics Inc. reported in an 8-K filed September 17, 2024 that Blai Coll, M.D., Ph.D. was appointed Chief Medical Officer, effective September 18, 2024.
“On September 17, 2024, the Company announced the appointment of Blai Coll, M.D., Ph.D., as the Company’s CMO as part of the planned succession replacing Dr. Bach, effective as of the Effective Date.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-09-18–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Structure Therapeutics Inc.
Other people whose current roles at this company are on record from its filings.
- Raymond Stevens CEO, Board Member
- Jun Yoon CFO
- Matthew Lang COO, General Counsel
- Yingli Ma CTO
- Angus Russell Board Member
- Ted Love, M.D. Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.